Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Growth Hormone (GH) Treatment in Spinal Cord Injury(SCI): A Triple-blinded, Randomised, Placebo-controlled Trial

NCT01329757 is registered in ClinicalTrials.gov with Hospital Nacional de Parapléjicos de Toledo as lead sponsor.

NCT NCT01329757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01329757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Growth Hormone (GH) Treatment in Spinal Cord Injury(SCI): A Triple-blinded, Randomised, Placebo-controlled Trial
Lead sponsor
Hospital Nacional de Parapléjicos de Toledo
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2011
Completion date
November 30, 2015
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury